CACI International Inc (NYSE:CACI) announced today that its Board of Directors has authorized the repurchase of up to $750 million of its common stock.
Related Posts
Nio Begins Shipping Charging Infrastructure To Norway Ahead Of September Deadline For Commencing Operations of Power Unit
NIO Inc.'s (NYSE: NIO) Norwegian foray appears on track, according to an update provided by the electric vehicle manufacturer.
Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study
The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with chemotherapy for never smoker patients with advanced non-small cell lung cancer (N
Production at Tesla’s TSLA.O Shanghai Factory on Track to Fall by Over a Third in Q2 vs Q1
-Reuters
https://www.reuters.com/business/autos-transportation/teslas-china-output-decline-trending-deeper-than-musk-forecast-data-internal-2022-06-09/#:~:text=SHANGHAI%2C%20June%209%20(Reuters),than%20Elon%20Musk%20had%20predicted.